RSV returns with a vengeance after COVID lockdowns

NCT ID NCT04959734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks RSV (respiratory syncytial virus) in UK children under 2, after COVID-19 disrupted normal seasonal patterns. Researchers are monitoring when RSV appears, how severe it is, and whether older children are affected. The goal is to help hospitals prepare for surges and protect high-risk infants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help predict and prepare for RSV surges, protecting at-risk children through timely immunisation.

What could go wrong

This is an observational study, not a treatment trial. Results may not apply to other countries or future seasons.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS; RESPIRATORY SYNCYTIAL VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiolitis respiratory syncytial virus bronchiolitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • University Hospitals of Leicester NHS Trust

    RECRUITING

    Leicester, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••